These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9374154)

  • 41. Cutaneous ulcers associated with hydroxyurea therapy.
    Quattrone F; Dini V; Barbanera S; Zerbinati N; Romanelli M
    J Tissue Viability; 2013 Nov; 22(4):112-21. PubMed ID: 24050921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photodermatosis secondary to hydroxyurea.
    Yanamandra U; Sahu KK; Malhotra P; Varma S
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25270158
    [No Abstract]   [Full Text] [Related]  

  • 43. Localised chronic eyedlid disease resulting from long term hydroxyurea therapy.
    Puri P; Woodcock BE; O'Donnell N
    Br J Ophthalmol; 2001 Mar; 85(3):372-3. PubMed ID: 11277103
    [No Abstract]   [Full Text] [Related]  

  • 44. [Severe hyponatremia with consciousness disturbance caused by hydroxyurea in a patient with chronic myeloid leukemia].
    Watanabe N; Tani M; Tanaka Y; Kurata M; Matsushita A; Maeda A; Nagai K; Takahashi T
    Rinsho Ketsueki; 2004 Mar; 45(3):243-6. PubMed ID: 15103940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydroxyurea dermopathy with a dermatomyositis-like eruption and a large leg ulcer.
    Suehiro M; Kishimoto S; Wakabayashi T; Ikeuchi A; Miyake H; Takenaka H; Okano A; Hirai H; Shimazaki C; Yasuno H
    Br J Dermatol; 1998 Oct; 139(4):748-9. PubMed ID: 9892930
    [No Abstract]   [Full Text] [Related]  

  • 46. Longitudinal pigmented nail bands during hydroxyurea therapy.
    Cakir B; Sucak G; Haznedar R
    Int J Dermatol; 1997 Mar; 36(3):236-7. PubMed ID: 9159017
    [No Abstract]   [Full Text] [Related]  

  • 47. Pseudo-dermatomyositis as a complication of hydroxyurea therapy.
    Marie I; Joly P; Levesque H; Heron F; Courville P; Cailleux N; Courtois H
    Clin Exp Rheumatol; 2000; 18(4):536-7. PubMed ID: 10949738
    [No Abstract]   [Full Text] [Related]  

  • 48. Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia.
    Vassallo C; Passamonti F; Merante S; Ardigò M; Nolli G; Mangiacavalli S; Borroni G
    Clin Exp Dermatol; 2001 Mar; 26(2):141-8. PubMed ID: 11298103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydroxyurea-induced gangrene of the toes in a patient with chronic myelogenous leukemia.
    Yasuda N; Ohmori S; Usui T
    Am J Hematol; 2000 Feb; 63(2):103-4. PubMed ID: 10629580
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cutaneous complications of long-term hydroxyurea therapy].
    Dem A; Diallo M; Gaye Fall MC; Dieng MM; Gaye M; Touré P
    Ann Dermatol Venereol; 2008 Nov; 135(11):800-1. PubMed ID: 19061670
    [No Abstract]   [Full Text] [Related]  

  • 51. Cutaneous manifestations of hydroxyurea therapy in childhood: case report and review.
    Issaivanan M; Mitu PS; Manisha C; Praveen K
    Pediatr Dermatol; 2004; 21(2):124-7. PubMed ID: 15078351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leg ulcer in a patient associated with hydroxyurea therapy.
    Dissemond J; Hoeft D; Knab J; Franckson T; Kroger K; Goos M
    Int J Dermatol; 2006 Feb; 45(2):158-60. PubMed ID: 16445510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hydroxyurea-induced melanonychia concomitant with a dermatomyositis-like eruption.
    Oh ST; Lee DW; Lee JY; Cho BK
    J Am Acad Dermatol; 2003 Aug; 49(2):339-41. PubMed ID: 12894095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Anhidrosis during long-term hydroxyurea therapy in a patient with chronic myelogenous leukemia].
    Takagi K; Nakamura T; Misaki H; Ueda T
    Rinsho Ketsueki; 2000 Nov; 41(11):1214-9. PubMed ID: 11193442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hydroxyurea-induced foot ulcer in a case of essential thrombocythaemia.
    Tsuchiya S; Ichioka S; Sekiya N
    J Wound Care; 2010 Aug; 19(8):361-4. PubMed ID: 20852510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leg ulcers and hydroxyurea: forty-one cases.
    Sirieix ME; Debure C; Baudot N; Dubertret L; Roux ME; Morel P; Frances C; Loubeyres S; Beylot C; Lambert D; Humbert P; Gauthier O; Dandurand M; Guillot B; Vaillant L; Lorette G; Bonnetblanc JM; Lok C; Denoeux JP
    Arch Dermatol; 1999 Jul; 135(7):818-20. PubMed ID: 10411157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The evolution of hydroxyurea therapy in chronic myelogenous leukemia.
    Kennedy BJ
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):21-6. PubMed ID: 1641653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nail changes in a patient with leukaemia.
    Bhaskar ME
    BMJ; 2011 Jan; 342():c6439. PubMed ID: 21224311
    [No Abstract]   [Full Text] [Related]  

  • 59. Acquired generalized ichthyosis in chronic myeloid leukaemia.
    Vinod KV; Verma S
    Natl Med J India; 2014; 27(5):291. PubMed ID: 26037441
    [No Abstract]   [Full Text] [Related]  

  • 60. Hydroxyurea-induced genital ulcers and erosions: Two case reports.
    Blum AE; Tsiaras WG; Kemp JM
    J Tissue Viability; 2021 Aug; 30(3):462-464. PubMed ID: 34147315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.